Amended Current Report Filing (8-k/a)
12 Enero 2023 - 4:16PM
Edgar (US Regulatory)
0001860514
true
0001860514
2023-01-10
2023-01-10
0001860514
USCT:UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember
2023-01-10
2023-01-10
0001860514
USCT:ClassOrdinarySharesParValue0.0001PerShareMember
2023-01-10
2023-01-10
0001860514
USCT:WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareEachAtExercisePriceOf11.50PerShareMember
2023-01-10
2023-01-10
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
Amendment
No. 2
Current
Report
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): January 10, 2023
TKB
CRITICAL TECHNOLOGIES 1
(Exact
name of registrant as specified in its charter)
| E9Cayman Island |
|
001-40959 |
|
98-1601095 |
(State
or Other Jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
Number) |
400
Continental Blvd, Suite 600
El
Segundo, CA 90245
(Address
of principal executive offices, including zip code)
Registrant’s
telephone number, including area code: (310) 426-2055
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☒ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| ☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| ☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| ☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Units,
each consisting of one Class A ordinary share and one-half of one redeemable warrant |
|
USCTU |
|
The Nasdaq Stock Market, LLC |
| Class
A ordinary shares, par value $0.0001 per share |
|
USCT |
|
The Nasdaq Stock Market, LLC |
| Warrants,
each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share |
|
USCTW |
|
The Nasdaq Stock Market, LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
EXPLANATORY
NOTE TO AMENDMENT NO. 2
This
Amendment No. 2 on Form 8-K/A (the “Amendment”) amends the Current
Report on Form 8-K of TKB Critical Technologies 1 (the “Company”), filed
on January 10, 2023 (the “Original Filing” and, as amended by Amendment
No. 1 on Form 8-K/A filed on January 11, 2023, the “Amended Original
Filing”), in which the Company reported its entry into a material definitive agreement relating to the Business
Combination (as defined therein). This Amendment is being filed to correct and replace in their entirety slides 5 and 24 of
the “Presentation for Investors of Wejo Group Limited,” dated January 10, 2023, attached as Exhibit 99.2 to the Original
Filing. The full presentation with the corrected slides (the “Corrected
Presentation”) is included with this Amendment. With the exception of the inclusion of the Corrected Presentation in replacement of Exhibit 99.2 to the Original Filing,
there were no changes to the Amended Original Filing.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits. The following exhibits are being filed herewith:
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
TKB
Critical Technologies 1 |
| |
|
| Date: January 12, 2023 |
By: |
/s/ Angela Blatteis |
| |
Name: |
Angela Blatteis |
| |
Title: |
Co-Chief Executive Officer and Chief Financial Officer |
Roth CH Acquisition (NASDAQ:USCT)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Roth CH Acquisition (NASDAQ:USCT)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
